Ling Li

Ling Li


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
XQXuan Qin
Xuan Qin
JLJiali Liu
Jiali Liu
YWYuning Wang
Yuning Wang
YLYanmei Liu
Yanmei Liu
KDKe Deng
Ke Deng
XSXin Sun
Xin Sun
To examine whether the use of natural language processing (NLP) technology is effective in assisting rapid title and abstract screening when updating a systematic review. Using the searched literature from a published systematic review, we trained and tested an NLP model that enables rapid title and abstract screening when updating a systematic review. The model was a light gradient boosting machine (LightGBM), an ensemble learning classifier which integrates four pretrained Bidirectional Encoder Representations from Transformers (BERT) models. We divided the searched citations into two sets (ie, training and test sets). The model was trained using the training set and assessed for screening performance using the test set. The searched citations, whose eligibility was determined by two independent reviewers, were treated as the reference standard. The test set included 947 citations; our model included 340 citations, excluded 607 citations, and achieved 96% sensitivity, and 78% specificity. If the classifier assessment in the case study was accepted, reviewers would lose 8 of 180 eligible citations (4%), none of which were ultimately included in the systematic review after full-text consideration, while decreasing the workload by 64.1%. NLP technology using the ensemble learning method may effectively assist in rapid literature screening when updating systematic reviews.

4 March 2024 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
YMYu Ma
Yu Ma
HXHunong Xiang
Hunong Xiang
JBJason W. Busse
Jason W. Busse
MYMinghong Yao
Minghong Yao
JGJian Guo
Jian Guo
XSXin Sun
Xin Sun

27 February 2024 in Phytomedicine
Verified
Journal Article
Open access
MNMingxin Ni
Mingxin Ni
YZYe Zhang
Ye Zhang
ZSZhenzhen Sun
Zhenzhen Sun
QZQing Zhou
Qing Zhou
JXJun Xiao
Jun Xiao
HCHaibo Cheng
Haibo Cheng
Colorectal adenoma is benign glandular tumor of colon, the precursor of colorectal cancer. But no pharmaceutical medication is currently available to treat and prevent adenomas. To evaluate efficacy of Shenbai Granules, an herbal medicine formula, in reducing the recurrence of adenomas. This multicenter, randomized, double-blind, placebo-controlled clinical trial was conducted by eight hospitals in China. Patients who had received complete polypectomy and were diagnosed with adenomas within the recent 6 months were randomly assigned (1:1) to receive either Shenbai granules or placebo twice a day for 6 months. An annual colonoscopy was performed during the 2-year follow-up period. The primary outcome was the proportion of patients with at least one adenoma detected in the modified intention-to-treat (mITT) population during follow-up for 2 years. The secondary outcomes were the proportion of patients with sessile serrated lesions and other specified polypoid lesions. The data were analyzed using logistic regression. Among 400 randomized patients, 336 were included in the mITT population. We found significant differences between treatment and placebo groups in the proportion of patients with at least one recurrent adenoma (42.5 % vs. 58.6 %; OR, 0.47; 95 % CI, 0.29-0.74; p = 0.001) and sessile serrated lesion (1.8 % vs. 8.3 %; OR, 0.20; 95 % CI, 0.06-0.72; p = 0.01). There was no significant difference in the proportion of patients developing polypoid lesions (70.7 % vs. 77.5 %; OR, 1.43; 95 % CI, 0.88-2.34; p = 0.15) or high-risk adenomas (9.0 % vs. 13.6 %; OR, 0.63; 95 % CI, 0.32-1.25; p = 0.18). Shenbai Granules significantly reduced the recurrence of adenomas, indicating that they could be an effective option for adenomas. Future studies should investigate its effects in larger patient populations and explore its mechanism of action to provide more comprehensive evidence for the use of Shenbai Granules in adenoma treatment.

21 February 2023 in Phytomedicine
Verified
Journal Article
Closed access
YLYanmei Liu
Yanmei Liu
XLXiaochao Luo
Xiaochao Luo
JLJiali Liu
Jiali Liu
YMYu Ma
Yu Ma
JTJing Tan
Jing Tan
XSXin Sun
Xin Sun

7 December 2024 in eClinicalMedicine
Verified
Journal Article
Open access
JHJiayidaer Huan
Jiayidaer Huan
MYMinghong Yao
Minghong Yao
YMYu Ma
Yu Ma
FMFan Mei
Fan Mei
YLYanmei Liu
Yanmei Liu
XSXin Sun
Xin Sun
Surgical interventions for spontaneous supratentorial intracerebral haemorrhage (ICH) include conventional craniotomy (CC), decompressive craniectomy (DC), and minimally invasive surgery (MIS), with the latter encompassing endoscopic surgery (ES) and minimally invasive puncture surgery (MIPS). However, the superiority of surgery over conservative medical treatment (CMT) and the comparative benefits of different surgical procedures remain unclear. We aimed to evaluate the efficacy and safety of various surgical interventions for treating ICH. In this systematic review and network meta-analysis, we searched PubMed, Cochrane Central Register of Controlled Trials, Embase, and ClinicalTrials.gov from inception to June 16, 2024. Eligible studies were randomised controlled trials (RCTs) comparing surgery (i.e., CC, ES, MIPS, or DC) with CMT or comparing different types of surgeries in patients with spontaneous supratentorial ICH. Paired reviewers independently screened citations, assessed the risk of bias of included trials, and extracted data. Primary outcomes were good functional outcome and mortality at 6 months. Secondary outcomes were good functional outcome and mortality at different follow-up times, complications (rebleeding, brain infection, pulmonary infection), and hematoma evacuation rate. The frequentist pairwise and network meta-analysis (NMA) were performed. The GRADE approach was used to evaluate the certainty of evidence. This study is registered with PROSPERO, CRD42024518961. Of the 8573 total records identified by our searches, 31 studies (6448 patients) were eligible for the systematic review and network analysis. Compared with CMT, moderate certainty evidence showed that surgery improved good functional outcome (risk ratio [RR] 1.31, 95% CI 1.13–1.52; risk difference [RD] 9.1%, 95% CI 3.8 to 15.3; I2 = 36%) and reduced mortality (RR 0.82, 95% CI 0.71–0.95; RD −5.1%, 95% CI −8.2 to −1.4; I2 = 14%). Moderate certainty evidence from NMA suggested that compared with CMT, both ES (RR 1.51, 95% CI 1.18–1.93; RD 9.4%, 95% CI 3.3–17.1) and MIPS (RR 1.48, 95% CI 1.24–1.76; RD 15.7%, 95% CI 7.9–24.9) improved good functional outcome at 6 months, and both ES (RR 0.66, 95% CI 0.52–0.85; RD −17.0%, 95% CI −24.0 to −7.5) and CC (RR 0.75, 95% CI 0.60–0.94; RD −6.3%, 95% CI −10.1 to −1.5) reduced mortality at 6 months, whereas MIPS and DC showed a trend, although not statistically significant, towards a reduction in mortality. ES and MIPS also reduced pulmonary infection risk (ES RR 0.39, 95% CI 0.23–0.69; MIPS RR 0.35, 95% CI 0.20–0.60; RD −5.3%, 95% CI −6.6 to −3.3). ES showed higher hematoma evacuation than CC (MD: 7.03, 95% CI: 3.42–10.65; I2 = 94%). No difference in rebleeding or brain infection was found between CC and MIS. Current moderate certainty evidence suggested that surgical intervention of spontaneous supratentorial ICH, may be associated with improved functional outcomes and a reduced risk of death at 6 months. The advantages of surgical haematoma removal are particularly pronounced when MIS including ES and MIPS are employed. ES could improve functional outcomes, reduce the risk of mortality and pulmonary infection, and have a high hematoma evacuation rate, suggesting that it might be an optimal surgical treatment. 10.13039/501100001809 National Natural Science Foundation of China , 10.13039/501100014219 National Science Fund for Distinguished Young Scholars , Fundamental Research Funds for the Central Public Welfare Research Institutes, and 1·3·5 project for disciplines of excellence, 10.13039/501100013365 West China Hospital, Sichuan University .

5 May 2025 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
MYMinghong Yao
Minghong Yao
FMFan Mei
Fan Mei
YMYu Ma
Yu Ma
XQXuan Qin
Xuan Qin
JHJiayidaer Huan
Jiayidaer Huan
XSXin Sun
Xin Sun